SUMO2 and cancer: Twenty-six transcription factors were represented in all groups, and included those implicated in diseases such as cancer (MYC, TP53, YAP1, RBL2, E2F7, BRD4, MXl1), inflammation (CEBPB, BHLHE40), oxidative stress (NFE2L2), and neurological conditions (NEUROG2, SUMO2).